This study aimed to detect the expression pattern of CXCR4 in patients with NET G3 and NEC, to correlate the level of expression with clinicopathological characteristics and survival, and to provide preliminary validation results for the diagnosis, differential diagnosis, prognosis prediction and targeted therapy of GEP-NEN G3. The gene discussed is CXCR4; the disease is neuroendocrine carcinoma.